skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Refine Results

Clear All

Specialism

もっと見る

Resources

もっと見る

Products

もっと見る

もっと見る

99+ Total results for product and free and sample content found

Biomedtracker: 開発中医薬品をFDA承認確率で評価

Biomedtracker 2018 Early Outlook Report

28 Jul 2022

Biomedtracker 2018 Early Outlook Report

What's on the horizon for pharma in 2018? Find out with Biomedtracker's Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.

Topic Drug Development Landscape

ターゲット市場の実像をつかむ

Profitability Assessment of Branded Generic Inhalers

By Ljlal Syed, Mark Lansdell and David Abramson 28 Jul 2022

Profitability Assessment of Branded Generic Inhalers

This report examines the extent to which order of market entry influences the prospects of achieving a satisfactory return on investment for companies developing branded generic

Topic Deals

ターゲット市場の実像をつかむ

Immuno-Oncology Overview

By Colin White, Robert Jeng & Jolene Lau 28 Jul 2022

Immuno-Oncology Overview

This is an overview of the field of immuno-oncology and the various immuno-oncology classes. Immuno-oncology is one of the most promising and fastest growing areas of cancer research, as well

Topic immuno-oncology

Scrip: 世界の医療用医薬品&製薬産業に関するニュース

Get your FREE extract of the 2021 Scrip Asia 100 Report Now | Pharma Intelligence

17 Jun 2022

Get your FREE extract of the 2021 Scrip Asia 100 Report Now | Pharma Intelligence

As we continue to navigate unprecedented times, the pharma industry in the Asia Pacific region has been persistently moving forward with clinical trial advancements.

Topic Business Strategies

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

In Vivo Outlook 2021 Report

16 Jun 2022

In Vivo Outlook 2021 Report

The highly anticipated Outlook 2022 report from Informa Pharma Intelligence is coming soon. Reach the thousands of senior decision makers who eagerly await this pharma industry ranking and review for the year ahead, with sponsorship opportunities that align your brand with our trusted information. 

Topic Deals BioPharmaceutical Business Strategies

In Vivo: 医療用医薬品・医療機器産業の経営層向けニュース

Outlook 2022: What Next for Pharma After a Year of Innovation and Growth?

02 Mar 2022

Outlook 2022: What Next for Pharma After a Year of Innovation and Growth?

Look ahead with our Pharma Outlook 2022 Extract as we discuss what's coming up in the biopharma space.

Biomedtracker: 開発中医薬品をFDA承認確率で評価, Meddevicetr...

Don’t miss your free extract of Early 2022 Outlook Report

08 Feb 2022

Don’t miss your free extract of Early 2022 Outlook Report

In pharma’s fast paced and continually evolving world, accurately anticipating the impact of events on the horizon is critical to your success.

Topic Business Strategies

Pharma Intelligence Apps

Not all news services are created equal

06 Jan 2022

Not all news services are created equal

Pharma Insights team of trusted journalists bring you the most critical news and analysis round the clock. Our global team of journalists and editors use their extensive experience and relationships with regulators, associations, and industry leaders to bring you in-depth insights so you can stay current on the latest market developments. Register for your free trial today to find out what our editors and journalists are reporting on now.

お問い合わせ&レポートストア

専任スタッフによるデモンストレーションを兼ねたサービスの詳しいご説明、または無料トライアルを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

*一部のサービスでは無料トライアルをご利用になれません。


新型コロナウイルス感染拡大防止のため在宅勤務を実施しています。

お問合せの際はフォームまたは下記メールアドレスをご利用頂くか、営業担当者の携帯電話までご連絡下さいますようご協力をお願い申し上げます。

インフォーマインテリジェンス合同会社
ファーマインテリジェンス
Eメール:
inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。